Citation: S. Erdogan et al., COMPARATIVE-EVALUATION OF THE FORMULATION, CHARACTERIZATION, STABILITY AND IN-VITRO RELEASE OF IOPROMIDE LIPOSOMES AND NIOSOMES, STP PHARMA SCIENCES, 8(2), 1998, pp. 127-132
Citation: F. Mazda et al., PREPARATION AND CHARACTERIZATION OF UREA NIOSOMES - IN-VITRO AND IN-VIVO STUDIES, STP pharma sciences, 7(3), 1997, pp. 205-214
Citation: Y. Yazan et al., PHARMACODYNAMIC COMPARISON OF A NASAL FORMULATION OF VERAPAMIL AND INTRAVENOUS AND ORAL DOSAGE FORMS, Drug development and industrial pharmacy, 22(3), 1996, pp. 281-284
Citation: Fs. Farshi et al., IN-VIVO STUDIES IN THE TREATMENT OF ORAL ULCERS WITH LIPOSOMAL DEXAMETHASONE SODIUM-PHOSPHATE, Journal of microencapsulation, 13(5), 1996, pp. 537-544
Citation: J. Almuhammad et al., STUDIES ON THE FORMULATION AND IN-VITRO RELEASE OF OPHTHALMIC LIPOSOMES CONTAINING DEXAMETHASONE SODIUM-PHOSPHATE, Journal of microencapsulation, 13(2), 1996, pp. 123-130
Citation: B. Arica et al., CHARACTERIZATION, IN-VITRO AND IN-VIVO STUDIES ON PRIMAQUINE DIPHOSPHATE LIPOSOMES, Journal of microencapsulation, 12(5), 1995, pp. 469-485
Citation: Ay. Ozer et al., TEMPERATURE-SENSITIVE AND PH-SENSITIVE LIPOSOMES, European journal of pharmaceutics and biopharmaceutics, 39(3), 1993, pp. 97-101